Severe immunosuppression (CD4 count ≤200 cells/mm³) was found in over half of the study participants.
NigeriaVIH/sidapublié 2022Oral surgery, oral medicine, oral pathology and oral radiologyPubMeddocument de 5 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 9 / 70
Severe immunosuppression (CD4 count ≤200 cells/mm³) was found in over half of the study participants.
NigeriaVIH/sidapublié 2022Oral surgery, oral medicine, oral pathology and oral radiologyPubMeddocument de 5 observations
20 %Poor adherence to ART was observed in almost 20% of the patients.
NigeriaVIH/sidapublié 2019The Pan African medical journalPubMeddocument de 5 observations
31,4 %Comparable proportions of respondents in peer support groups (31.4%) and non-peer support groups (30.2%) had self-stigma.
NigeriaVIH/sidapublié 2019The Pan African medical journalPubMeddocument de 2 observations
29,4 %Among 17 HIV-infected, HIV-exposed infants in Plateau State, Nigeria who experienced treatment mortality or losses (TX_ML), 29.4% (5/17) transferred out.
NigeriaVIH/sidaobservé 2018–2022publié 2026PloS onePubMeddocument de 13 observations
68 %68% of the participants experienced financial challenges in accessing care during the COVID-19-induced lockdown.
NigeriaVIH/sidapublié 2022Nigerian journal of clinical practicePubMeddocument de 9 observations
2,97 aORFemale sex workers residing in the South West geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 2.97).
NigeriaVIH/sidapublié 2024International journal of STD & AIDSPubMeddocument de 12 observations
82 %In Nigeria, 82% of pregnant women received HIV/PMTCT counsel during antenatal care.
NigeriaVIH/sidaobservé 2018publié 2023BMC health services researchPubMeddocument de 13 observations
4,4 %The prevalence of HCV infection among HIV-infected people in Port Harcourt, Rivers State was 4.4%.
Nigeriahépatite C · VIH/sidapublié 2021African health sciencesPubMeddocument de 4 observations
97,8 %Retention rate at 12 months was 97.8% among adults enrolled in differentiated service delivery models compared to 96.7% among children, with a p-value of 0.04.
NigeriaVIH/sidapublié 2021Journal of the International AIDS SocietyPubMeddocument de 6 observations
96 %96% of the participants living with HIV/AIDS disclosed their HIV sero-status.
NigeriaVIH/sidapublié 2019West African journal of medicinePubMeddocument de 2 observations
38,84 %In envelope (env) gp120, 38.84% of the HIV-1 samples reacted to a G probe.
NigeriaVIH/sidapublié 2016MedicinePubMeddocument de 7 observations
7,1 %Among HIV-1 isolates from patients receiving first-line ART in South-eastern Nigeria, unclassifiable UG accounted for 7.1% of the 28 sequenced isolates.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 11 observations
3,4 aORThose who had never missed a clinic appointment were three times more likely to adhere to prescribed HIV medication, with an adjusted odds ratio of 3.4.
NigeriaVIH/sidapublié 2021West African journal of medicinePubMeddocument de 3 observations
9,3 %At repeat evaluation, the proportion of type C tympanogram was 9.3% in the right ear and 6.7% in the left ear among 150 HIV-positive patients.
NigeriaVIH/sidapublié 2023Nigerian journal of clinical practicePubMeddocument de 6 observations
1 %The prevalence of HIV infection among siblings of HIV-positive children in care in Calabar was 1%.
NigeriaVIH/sidapublié 2019The Pan African medical journalPubMeddocument de 6 observations
3 000 nairaThe mean amount patients living with HIV were willing to pay was 3,000 naira (US$7.50) per month.
NigeriaVIH/sidapublié 2022Global health, science and practicePubMeddocument de 4 observations
7,1 %The overall prevalence of isoniazid preventive therapy (IPT) uptake was 7.1% among HIV-infected patients in the study.
NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 4 observations
4,51 %There was a 4.51% overall difference in health-related quality of life (HRQoL) between male and female HIV patients, with a 95% confidence interval of 3.63% to 5.39%.
NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 3 observations
There was a significant difference in neutrophil count between females (40.9 ± 11.7) and males (36 ± 31.1) infected with EBV IgM in HIV individuals.
NigeriaVIH/sida · virus Epstein-Barrpublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 15 observations
55 %The simplest definition classified 55% of women as retained in care.
NigeriaVIH/sidaobservé 2013–2017publié 2020Journal of the International AIDS SocietyPubMeddocument de 3 observations
57,1 %Among HIV-1 isolates from patients receiving first-line ART in South-eastern Nigeria, CRF02_AG accounted for 57.1% of the 28 sequenced isolates.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 11 observations
48,5 %HIV testing uptake among undergraduate students in Imo State, Nigeria, was 48.5% at University of Agriculture and Environmental Sciences (UAES) in the past year.
NigeriaVIH/sidapublié 2026Scientific reportsPubMeddocument de 5 observations
76,3 %The frequency of cognitive impairment among CART-naïve patients was 76.3% (29 out of 38 patients).
NigeriaVIH/sidapublié 2026Annals of African medicinePubMeddocument de 7 observations
66 %The overall prevalence of latent tuberculosis infection among HIV-infected patients, considering positivity to either tuberculin skin test or QuantiFERON-TB Gold In-Tube assay, was 66%.
Nigerialatent tuberculosis infection · VIH/sidapublié 2021The Pan African medical journalPubMeddocument de 5 observations
37 900 000 inhabitantsThere were approximately 37.9 million persons infected with HIV globally in 2018.
NigeriaVIH/sidaobservé 2018publié 2021Journal of medical virologyPubMeddocument de 11 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.